Luther King Capital Management (LKCM)
CRL icon

Luther King Capital Management (LKCM)’s Charles River Laboratories CRL Stock Holding History

Luther King Capital Management (LKCM)’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.2M Sell
53,812
-1,255
-2% -$223K 0.05% 169
2026
Q1 		$9.5M Sell
55,067
-9,694
-15% -$1.8M 0.04% 183
2025
Q4 		$12.9M Buy
64,761
+17,781
+38% +$3.23M 0.05% 159
2025
Q3 		$7.35M Sell
46,980
-5,220
-10% -$829K 0.03% 197
2025
Q2 		$7.92M Buy
52,200
+6,802
+15% +$907K 0.03% 190
2025
Q1 		$6.83M Sell
45,398
-6,945
-13% -$1.16M 0.03% 196
2024
Q4 		$9.66M Sell
52,343
-13,346
-20% -$2.57M 0.04% 163
2024
Q3 		$12.9M Sell
65,689
-252,657
-79% -$52.5M 0.06% 143
2024
Q2 		$65.8M Sell
318,346
-32,859
-9% -$7.45M 0.3% 75
2024
Q1 		$95.2M Sell
351,205
-15,629
-4% -$3.73M 0.43% 61
2023
Q4 		$86.7M Sell
366,834
-18,784
-5% -$3.69M 0.42% 66
2023
Q3 		$75.6M Sell
385,618
-16,289
-4% -$3.34M 0.39% 67
2023
Q2 		$84.5M Sell
401,907
-10,656
-3% -$2.12M 0.42% 66
2023
Q1 		$83.3M Sell
412,563
-18,033
-4% -$4.09M 0.44% 69
2022
Q4 		$93.8M Sell
430,596
-48,499
-10% -$10.6M 0.51% 65
2022
Q3 		$94.3M Sell
479,095
-38,065
-7% -$8.22M 0.56% 57
2022
Q2 		$111M Sell
517,160
-48,538
-9% -$11.9M 0.62% 52
2022
Q1 		$161M Buy
565,698
+10,598
+2% +$3.27M 0.78% 41
2021
Q4 		$209M Buy
555,100
+9,159
+2% +$3.56M 0.95% 33
2021
Q3 		$225M Sell
545,941
-2,132
-0.4% -$885K 1.11% 25
2021
Q2 		$203M Buy
548,073
+18,519
+3% +$6.18M 0.99% 31
2021
Q1 		$153M Buy
529,554
+52,821
+11% +$14.7M 0.82% 37
2020
Q4 		$119M Buy
476,733
+54,216
+13% +$12.9M 0.67% 46
2020
Q3 		$95.7M Buy
422,517
+13,958
+3% +$2.9M 0.6% 49
2020
Q2 		$71.2M Buy
408,559
+10,501
+3% +$1.68M 0.49% 59
2020
Q1 		$50.2M Sell
398,058
-3,636
-0.9% -$545K 0.44% 65
2019
Q4 		$61.4M Buy
401,694
+35,500
+10% +$4.92M 0.41% 70
2019
Q3 		$48.5M Buy
366,194
+22,417
+7% +$3.01M 0.35% 74
2019
Q2 		$48.8M Buy
343,777
+220,562
+179% +$29.9M 0.36% 74
2019
Q1 		$17.9M Buy
123,215
+30,780
+33% +$4.04M 0.14% 110
2018
Q4 		$10.5M Buy
92,435
+21,172
+30% +$2.65M 0.09% 133
2018
Q3 		$9.59M Sell
71,263
-1,265
-2% -$156K 0.07% 148
2018
Q2 		$8.14M Sell
72,528
-7,940
-10% -$858K 0.07% 152
2018
Q1 		$8.59M Sell
80,468
-5,370
-6% -$579K 0.07% 150
2017
Q4 		$9.39M Sell
85,838
-4,975
-5% -$541K 0.08% 154
2017
Q3 		$9.81M Sell
90,813
-7,175
-7% -$737K 0.09% 140
2017
Q2 		$9.91M Sell
97,988
-15,965
-14% -$1.47M 0.09% 140
2017
Q1 		$10.3M Sell
113,953
-31,100
-21% -$2.64M 0.09% 140
2016
Q4 		$11.1M Sell
145,053
-57,640
-28% -$4.38M 0.11% 140
2016
Q3 		$16.9M Sell
202,693
-38,365
-16% -$3.22M 0.17% 112
2016
Q2 		$19.9M Sell
241,058
-22,400
-9% -$1.85M 0.19% 111
2016
Q1 		$20M Sell
263,458
-141,065
-35% -$10.4M 0.2% 112
2015
Q4 		$32.5M Sell
404,523
-61,532
-13% -$4.44M 0.3% 85
2015
Q3 		$29.6M Sell
466,055
-41,115
-8% -$2.95M 0.29% 88
2015
Q2 		$35.7M Sell
507,170
-7,595
-1% -$562K 0.31% 82
2015
Q1 		$40.8M Buy
514,765
+8,255
+2% +$609K 0.34% 76
2014
Q4 		$32.2M Buy
506,510
+135,500
+37% +$8.49M 0.26% 111
2014
Q3 		$22.2M Buy
+371,010
New +$21.2M 0.18% 148

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Luther King Capital Management (LKCM)'s CRL Position: Q2 2026 in Review

Luther King Capital Management (LKCM) reduced its Charles River Laboratories (CRL) stake by 2.3% in Q2 2026, selling an estimated $223K and leaving 53,812 shares worth $12.2M. The position accounts for 0.05% of the portfolio, ranked #169.

Luther King Capital Management (LKCM) first reported a position in CRL in Q3 2014 and has held it in 48 quarters since. The position peaked at $225M in Q3 2021. 563 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Luther King Capital Management (LKCM) held 53,812 shares of Charles River Laboratories worth $12.2M as of Q2 2026.
  • Luther King Capital Management (LKCM) sold 1,255 Charles River Laboratories shares in Q2 2026, an estimated $223K.
  • Charles River Laboratories made up 0.05% of Luther King Capital Management (LKCM)'s portfolio in Q2 2026, its #169 holding.
  • Luther King Capital Management (LKCM) first reported a position in Charles River Laboratories in Q3 2014 and has held it in 48 quarters since.
  • Luther King Capital Management (LKCM)'s Charles River Laboratories position peaked at $225M in Q3 2021.
  • 563 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Luther King Capital Management (LKCM)'s 13F filing for Q2 2026, filed 10 Aug 2026.